(Q36726178)

English

Effect of reducing the dose of stavudine on body composition, bone density, and markers of mitochondrial toxicity in HIV-infected subjects: a randomized, controlled study

scientific article published on April 2008

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

15 August 2017

Effect of reducing the dose of stavudine on body composition, bone density, and markers of mitochondrial toxicity in HIV-infected subjects: a randomized, controlled study (English)

1 reference

Europe PubMed Central

15 August 2017

1 reference

based on heuristic

inferred from title

1

object named as

G A McComsey

1 reference

Europe PubMed Central

15 August 2017

author name string

V Lo Re

2

1 reference

Europe PubMed Central

15 August 2017

M O'Riordan

3

1 reference

Europe PubMed Central

15 August 2017

U A Walker

4

1 reference

Europe PubMed Central

15 August 2017

D Lebrecht

5

1 reference

Europe PubMed Central

15 August 2017

E Baron

6

1 reference

Europe PubMed Central

15 August 2017

K Mounzer

7

1 reference

Europe PubMed Central

15 August 2017

I Frank

8

1 reference

Europe PubMed Central

15 August 2017

language of work or name

0 references

publication date

1 April 2008

1 reference

Europe PubMed Central

15 August 2017

Clinical Infectious Diseases

1 reference

Europe PubMed Central

15 August 2017

46

1 reference

Europe PubMed Central

15 August 2017

8

1 reference

Europe PubMed Central

15 August 2017

1290-1296

1 reference

Europe PubMed Central

15 August 2017

Systematic review of clinical trials evaluating low doses of stavudine as part of antiretroviral treatment

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2430521

30 September 2017

Pathogenesis of osteopenia/osteoporosis induced by highly active anti-retroviral therapy for AIDS.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2430521

30 September 2017

Mitochondrial toxicity induced by nucleoside-analogue reverse-transcriptase inhibitors is a key factor in the pathogenesis of antiretroviral-therapy-related lipodystrophy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2430521

30 September 2017

Reversibility of lipoatrophy in HIV-infected patients 2 years after switching from a thymidine analogue to abacavir: the MITOX Extension Study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2430521

28 June 2018

The impact of reducing stavudine dose versus switching to tenofovir on plasma lipids, body composition and mitochondrial function in HIV-infected patients

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2430521

5 September 2018

Role of mitochondria in HIV lipoatrophy: insight into pathogenesis and potential therapies

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2430521

5 September 2018

Extensive investigations of mitochondrial DNA genome in treated HIV-infected subjects: beyond mitochondrial DNA depletion

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2430521

5 September 2018

Increased adipocyte apoptosis in lipoatrophy improves within 48 weeks of switching patient therapy from Stavudine to abacavir or zidovudine

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2430521

5 September 2018

Effects of of didanosine-related depletion of mtDNA in human T lymphocytes

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2430521

5 September 2018

Improvements in lipoatrophy, mitochondrial DNA levels and fat apoptosis after replacing stavudine with abacavir or zidovudine

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2430521

5 September 2018

Improvement in lipoatrophy associated with highly active antiretroviral therapy in human immunodeficiency virus-infected patients switched from stavudine to abacavir or zidovudine: the results of the TARHEEL study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2430521

5 September 2018

Mitochondrial DNA depletion and morphologic changes in adipocytes associated with nucleoside reverse transcriptase inhibitor therapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2430521

5 September 2018

Changes in mitochondrial DNA as a marker of nucleoside toxicity in HIV-infected patients

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2430521

5 September 2018

Osteopenia in HIV-infected men: association with asymptomatic lactic acidemia and lower weight pre-antiretroviral therapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2430521

5 September 2018

A randomized comparative trial of tenofovir DF or abacavir as replacement for a thymidine analogue in persons with lipoatrophy

1 reference

https://api.crossref.org/works/10.1086%2F529384

21 January 2018

Effects of pH on bone calcium and proton fluxes in vitro

1 reference

https://pubmed.ncbi.nlm.nih.gov/18444869

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Tissue-specific associations between mitochondrial DNA levels and current treatment status in HIV-infected individuals

1 reference

https://pubmed.ncbi.nlm.nih.gov/18444869

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Incidence of and risk factors for lipoatrophy (abnormal fat loss) in ambulatory HIV-1-infected patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/18444869

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Contribution of nucleoside analogue reverse transcriptase inhibitors to subcutaneous fat wasting in patients with HIV infection

1 reference

https://pubmed.ncbi.nlm.nih.gov/18444869

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Evidence of nucleoside analogue reverse transcriptase inhibitor--associated genetic and structural defects of mitochondria in adipose tissue of HIV-infected patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/18444869

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

1 reference

Europe PubMed Central

15 August 2017

release_27c6vs2iknbyndy555i3nuzlhi

1 reference

https://api.fatcat.wiki/v0/release/27c6vs2iknbyndy555i3nuzlhi

24 November 2022

based on heuristic

mapped directly with Wikidata item

1 reference

Europe PubMed Central

15 August 2017

1 reference

Europe PubMed Central

15 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q36726178&oldid=1945346409"